Cangen Biotechnologies Names Christian Nascimento as Director of Finance; Former MBNA Financial Manager Expands Executive Team.BETHESDA, Md. -- Cangen Biotechnologies, Inc. today announced that Christian Nascimento, formerly a Financial Manager at MBNA MBNA Monument Builders of North America MBNA Mercedes-Benz North America MBNA Maryland Bank, National Association MBNA Maryland Bank North America MBNA Mount Baker Nurses Association (Bellingham, Washington) , a leading international financial services company providing lending, deposit, and credit insurance products and services, was named Director of Finance and has joined the company's senior management team. "We are excited to have another experienced financial professional join our senior management to support the company's continued growth," said Chul So Moon, M.D., Ph.D., Chief Executive Officer and Chief Science Officer of Cangen Biotechnologies. Richard Silfen, President and CFO See Chief Financial Officer. agreed, "Christian's experience on financial controls, Sarbanes-Oxley compliance and operational issues will enable the company to be well positioned for future expansion." Mr. Nascimento is a graduate of Widener University and is currently a MBA MBA abbr. Master of Business Administration Noun 1. MBA - a master's degree in business Master in Business, Master in Business Administration candidate at Villanova University. Prior to joining Cangen, he was a financial consultant with PricewaterhouseCoopers, held financial management and analysis positions at several public investment firms and most recently was part of the financial management team at MBNA, the largest independent credit card lender in the world. He will be based in the company's Bethesda headquarters. Cangen Biotechnologies, Inc. is a cancer-focused biotechnology company developing non-invasive diagnostic tests for early detection of cancer, chemosensitivity technologies to enhance the selection of cancer therapeutic regimes as well as targeted drug and biologic cancer therapies, including vaccines. The company is currently enrolling patients in a Phase 3 study to evaluate a diagnostic test for the early detection of bladder cancer bladder cancer Malignant tumour of the bladder. The most significant risk factor associated with bladder cancer is smoking. Exposure to chemicals called arylamines, which are used in the leather, rubber, printing, and textiles industries, is another risk factor. , based on microsatellite See miniaturized satellite. DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. alterations. Cangen Biotechnologies is based in Bethesda, MD, has laboratories in Rockville, MD and Baltimore, MD and has operations in Seoul, Korea and Tokyo, Japan. Cangen is on the World Wide Web at http://www.cangenbio.com |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion